Share Ownership
- January 2009: 11.29% by Total; 8.99% by L'Oréal (30.8% by the Bettencourt Family, 29.6% by Nestlé).
- January 2008: 12.70% by Total; 8.66% by L'Oréal.
- March 2007: 13.12% by Total; 10.52% by L'Oréal.
- Share ownership (January 2006): 12.74% by Total; 10.21% by L'Oréal.
- January 2005: 12.65% by Total; 10.13% by L'Oréal.
- January 2004 (Sanofi-Synthélabo): 24.35% by Total; 19.52% by L'Oréal.
- Sanofi-Synthélabo after the merger: 35.3% by Total; 19.52% by L'Oréal.
Executive and Management Committee
Christopher A. Viehbacher
- Chief Executive Officer since December 2008.
- Career beginning at PriceWaterhouseCoopers.
- 1988-2008: At GlaxoSmithKline. Last position: President, Pharmaceutical Operations North America, member of the board and Co-Chairman of the Portfolio Management Board.
- Board member of PhRMA in the United States.
- German and Canadian nationalities and knight of the French Legion of Honor in 2003.
Jérôme Contamine
- Executive Vice President and Chief Financial Officer since March 2009.
- Graduate of Ecole Polytechnique, France's most prestigious engineering school, and ENSAE, the national statistics and economics engineering school, affiliated with the Ministry of Finance (1982).
- Graduated from the elite Ecole Nationale d’Administration opting for the Court of Audit of France in 1984.
- Advisor to the Chief Financial Officer (1988) and Group Finance Director & Treasurer (1991) at Elf Aquitaine.
- General Manager of Elf Petroleum Norway (1995).
- Deputy Vice President of Elf Upstream Division for Europe and the U.S.
- Head of the taskforce for integration with Total (1999), in charge of the reorganization of the merged entity, TotalFinaElf.
- Vice President Europe and Central Asia Upstream Division of Total (2000).
- CFO and Deputy General Manager of Vivendi Environnement (2000).
- Senior Executive Vice President, Deputy General Manager and Chief Financial Officer of Veolia Environment (2003).
Hanspeter Spek
- Executive Vice President Pharmaceutical Operations (2004-2009); President Global Operations since November 2009.
- Management training program at Pfizer International, and joined Pfizer RFA as a junior product manager and various positions.
- Marketing Director at Sanofi Pharma GmbH, a German subsidiary of Sanofi, in 1985, and various positions in Germany and France.
- Senior Vice President Europe following the merger with Synthélabo in 1999.
- Executive Vice President International Operations (2000-2003).
- Worldwide operations of Sanofi-Synthélabo (2003-2004).
Marc Cluzel
- Senior Vice President Research and Development Scientific and Medical Affairs (2007-2009); Executive Vice President Research & Development since November 2009.
- Researcher at Johns Hopkins University (Baltimore) and Guy's Hospital (London).
- At Sanofi Recherche as Clinical pharmacologist (1991), Senior Project Director (1993), Vice President Research Projects Management (1996), Vice President International Development (2001).
Laurence Debroux
- Senior Vice President Chief Strategic Officer since February 2009.
- Graduate of Ecole des Hautes Etudes Commerciales.
- Career begining at Merrill Lynch in London.
- Finance Department of the Elf Aquitaine Group, Total, (1993-1996).
- Corporate Treasurer (1996), Head of Financing/Treasury (1997), Head of Strategic Planning (2000-2004), Deputy Chief Financial Officer (2004-2007), Senior Vice President Chief Financial Officer (2007) at Sanofi Group.
Karen Linehan
- Senior Vice President Legal Affairs and General Counsel since March 2007.
- Bachelor of arts and juris doctorate degrees from Georgetown University.
- Congressional staff of the Speaker of the U.S. House of Representatives (1977-1986).
- Associate in a law firm in New York (1986-1996).
- Assistant General Counsel of US Sanofi subsidiary (1996) and positions at Sanofi Group within the Legal Department like Vice President Deputy Head of Legal Operations.
Philippe Luscan
- Senior Vice President Industrial Affairs.
- Graduated from Ecole Polytechnique and Ecole des Mines of Paris in biotechnologies.
- Head of production at Danone (1987).
- Head of site at Sanofi Chemistry in Sisteron (1990), Head of industrial affairs at Sanofi in the United States, Vice President Supply Chain, Vice President Chemistry (2006).
Roberto Pucci
- Senior Vice President Human Resources since October 2009.
- Executive Vice President Human Resources for the Fiat Group in Torino, Italy (2007).
- Senior Vice President Human Resources at Case New Holland, US subsidiary of the Fiat Group (2005).
- Director Compensation & Benefits (1999) and Vice President Human Resources Europe (2003) for Agilent Technologies (spin off from Hewlett-Packard).
- Various positions in Human Resources in Switzerland and Italy including HR Manager for the European Headquarter and Human Resources Director in Italy at Hewlett-Packard (1987).
- External auditor at Coopers & Lybrand in Geneva, Switzerland (1985).
- Law degree from the University of Lausanne, Switzerland.
Wayne Pisano
- Senior Vice President Vaccines since August 2007.
- Vice President U.S. Marketing (1997), Senior Vice President of US Marketing & Sales, Executive Vice President North America and Senior Vice President Global Commercial Operations at Sanofi Pasteur.
- Various marketing and sales positions with Reed & Carnrick Pharmaceuticals and Sandoz/Novartis.
- Bachelor's degree in biology from St. John Fisher College, Rochester, New York; MBA from the University of Dayton, Ohio.
Management Committee
Philippe Fauchet
- President of GSK Japan since 2010.
- Senior Vice President Business Development since January 2009.
- Advisor to the French Foreign Trade Commission.
- Vice President Eastern Europe (1999); Head of Japanese operations (2001); Senior Vice President Pharmaceuticals Operation Japan (2005) at Sanofi-Synthélabo.
- Vice President of the Asia-Pacific region for Hoechst Marion Roussel.
- Number of posts in France, Japan and Korea at Roussel Uclaf (1984).
- At Sanofi (1996); Head of the Eastern Europe region (1997).
- At a subsidiary of Renault (1982-1984).
- Graduate of Ecole des Hautes Etudes Commerciales, and law degree.
Marie-Hélène Laimay
- Senior Vice President Audit and Internal Control Assessment since August 2004.
- Sanofi (1985) in a variety of financial positions, Vice President Internal Audit (2000-2002), Senior Vice President Chief Financial Officer (2002-2004).
- Auditor with Ernst & Young (1982-1985).
Christian Lajoux
- Senior Vice President Pharmaceutical Operations France since August 2004.
- Degree in psychology, Master Degree in Philosophy from Nancy University, and Advanced Management degree from Paris IAE.
- Variety of positions at Sandoz, including Division Director.
- Sanofi Winthrop (1993); Various positions including Director of Operations and Managing Director France; Senior Vice President France (1999-2003); Senior Vice President Europe (2003-2004).
- Chairman of the French Pharmaceutical Companies Association (Les entreprises du médicament) since July 2006.
- Member of the French Council for Heatlh Insurance.
- President of the French Federation of Health Industries.
- Board Member of INSERM, the National Institute for Health and Medical Research, and AFSSAPS, the French Health agency.
- Officer of the Legion of Honour.
Jean-Pierre Lehner
- Vice President Medical Affairs Europe (2003-2005); Senior Vice-President Medical & Regulatory Affairs since 2005; Senior Vice President Chief Medical Officer since February 2009.
- Scientific Senior Director of Sanofi Winthrop (1996-2002).
- Senior Director of Clinical Investigations of Sanofi Recherche (1992-1996).
- Medical Director at Roussel-Uclaf (1986-1992) and Roussel Laboratories (1981-1986).
- Chef de Clinique, assistant of Paris Hospitals, Department of Cardiology, Hôpital Bichat, Paris, France (1977-1981).
- Medical degree from the School of Medicine University of Paris, France.
Jean-Philippe Santoni
- Vice President International Clinical Development; Senior Vice President International Development R&D; Senior Vice President Industrial Development and Innovation within the Industrial Affairs since June 2009.
- Vice President International Clinical Operations at Sanofi-Synthélabo.
- Cardiovascular Development Director at Synthélabo (1990).
- At Servier (1984).
- Master of Sciences and post-graduate degree in statistics applied to medicine.
Laure Thibaud
- Senior Vice President Communications since June 2009.
- Global Executive Vice President Communications and Sustainable Development of the AXA Group (2007).
- 1990-2007 at GSK Group: Head of Public Relations and Director of Communications in France; Vice President Communications Europe in London; Vice President External Affairs Europe in Brussels.
- Communication Manager for Alain Afflelou.
Board of Directors
Jean-Marc Bruel (1936-)
- Board of Directors since 2004.
- President and Chairman of Firmenich S.A. and Board of Villette-Entreprises Foundation.
- Vice-Chairman (1992) and President (1987-1992) of Groupe Rhône-Poulenc.
- Board of Directors at Rhodia S.A. (2002).
- Supervisory Board of Banque Paribas.
- Director of Surveillance of Aventis, Ecole Centrale de Paris, and Institut Curie.
Klaus Pohle (1938-)
- Board of Directors since August 2004.
- Chairman of the German Accounting Standards Board.
- Vice-Chairman of the Supervisory Board of Hypo Real Estate Holding AG (Germany).
- Director of Labelux Group GmbH (Austria).
- Supervisory Board and Chairman of the Audit Committee of DWS Investment GmbH (Germany).
- Director and Chairman of the Audit Committee of Coty Inc., New York.
Jean-René Fourtou (1940-)
- Board of Directors since 2004.
- Board of Directors of Nestlé (since 2006); Cap Gemini S.A. (since 2002), France; NBC Universal, USA; Maroc Télécom, Morocco; Schneider Electric; La Poste; Pernod-Ricard S.A.; and Rhodia.
- Chairman of the Supervisory Board of Canal+ Group, France.
- Vice Chairman of the Supervisory Board of AXA Group.
- Consulting Engineer in organizational management at Bossard & Michel (1963-1972).
- CEO of Bossard Consultants (1972).
- Chairman and CEO of the Bossard Group (1977-1986).
- Chairman and CEO of Rhône-Poulenc Group (1986-1999).
- Chairman (1992-1993) and Honorary Chairman of the Association of Companies for the Environment.
- Chairman (1992-1994) and Honorary Chairman of the French Movement for Quality.
- Vice Chairman of the Management Board and Managing Director of Aventis (1999-2002).
- Director of European Aeronautic Defence and Space Company (2000).
- Chairman and CEO (2002-2005) and Chairman of the Supervisory Board (2005) of Vivendi.
- Chairman (2003-2004) and Honorary Chairman of International Chamber of Commerce.
- Commander of the Legion of Honour in 2008, Officer of the Legion of Honour in 1996 and Commander of the National Order of Merit in 2003.
- Commander of the Order of Ouissam Alaouite (Morocco, 2005) and Commander of the Order of Ouissam al Moukafaa al Watanya (Morocco, 2005).
Jean-Francois Dehecq (1940-)
- Chairman of the Board of Directors (-2010).
- President of Sanofi-Synthélabo Daiichi Pharmaceuticals Co. Ltd.
- General Manager of Sanofi (1973-1999); President and Director-General of Sanofi-Synthelabo (1999-2007); Permanent Representative of Sanofi-Synthélabo at the Board of Sanofi-Synthélabo Recherche (France); Director of Fujisawa Sanofi-Synthélabo (Japan) and Sanofi-Synthélabo Inc., United States.
- President of The European Federation of Pharmaceutical Industries and Associations.
- Director of Finance at Management, Financière Yves Rocher and Laboratoires Daiichi Sanofi-Synthélabo (France).
- Chairman of Policy Committee of the French Strategic Investment Found.
- Director of Air France, Air France-KLM, (since 1995); Agence Nationale de la Recherche; Pechiney (since 1994); Balmain (Belgium); Paris EUROPLACE; and Veolia Environnement (since 2006).
- Member of IFPMA (International Federation of Pharmaceutical Manufacturers Associations), and Fondation Francaise pour la Recherche sur l'Epilepsie.
- Chairman of Association Nationale de la Recherche Technique.
- Graduate and Chairman of the Board of Directors of ENSAM (Ecole Nationale Superieure d'Arts et Metiers).
- Supervisory Board of the Agency for Industrial Innovation.
- Teaching mathematics at the Saint-Vincent de Senlis Catholic College (1964-1965)
- Trainee in scientific research in the Army's Nuclear Propulsion Department.
- Economics departments (1965-1969) and assistant to management (1969-1970) at Elf Aquitaine.
- Operating engineer at the Lacq Factory (1970-1971).
- Managing Director (1971), Managing Director (1982-1988) and Vice-President of Sanofi.
- Executive Vice President of Health at ELF Aquitaine Group (1988).
- Former Director of Alcan France S.A.S.
Gerard Van Kemmel (1940-)
- Board of Directors since 2003.
- Director of Groupe Eurotunnel, Eurotunnel NRS Holders Company Limited (UK), and GET S.A. since 2008.
- Audit Committee and Director of Europacorp since 2008.
- President of Europe Middle East Africa Division (2001) and President Europe (2002-2004) of Novell Inc.
- Senior Vice President (1997-1999); Chief Operating Officer and Executive Vice President (1999-2001) of Cambridge Technology Partners Massachusetts Inc.
- Technical Advisor to the French Minister of Finance (1996-1997).
- Chairman of Continental Europe for Peter Chadwick Holdings Limited (1997).
- Many positions at Andersen Consulting (1966-1996).
- Graduated from Hautes Etudes Commerciales in Paris and MBA from Stanford Business School.
Igor Landau (1945-)
- Board of Directors since 2004.
- Board of Directors of HSBC France.
- Supervisory Board of Adidas AG (deputy chairman) and Allianz.
- President of La Compagnie du Roneo (1968-1970).
- Consultant of McKinsey & Company (1971-1975).
- Deputy to President in health division (1975-1977), executive vice president in health division (1977-1980), president of health division (1980-1992), and president (1992-1998) at Rhône-Poulenc Group.
- President of pharmaceutical division and Board member (1998-2002); Chairman and CEO (2002-2004) of Aventis.
Arthur Charles Valerian Douro (1946-)
- Board of Directors since 2002.
- Director of Pernod-Ricard S.A., Compagnie Financière Richemont AG (Switzerland), GAM Worldwide (UK), and Abengeo Bioenergy (Spain).
- Commissioner of English Heritage.
- Senior Advisor of Calyon (UK).
- Chairman of Richemont Holdings Limited, Framlington Group, Kings College London, Sun Life & Provincial Holdings, AXA (1995-2000), and Dunhill Holdings.
- Deputy Chairman of Vendôme Luxury Group.
- Non-Executive Director of Compagnie Financiere Richemont AG (2000).
- Member of the European Parliament (1979-1989).
- MA degree from Oxford University.
Owe Bicker, M.D., Ph.D. (1946-)
- Board of Directors since 2008.
- Professor of University of Heidelberg Medical School.
- Managing Director of Behringwerke AG.
- Executive Chairman of Scil Holding GmbH.
- Chairman of the Supervisory Board of Dade Behring Holding GmbH (2005).
- Supervisory Board (2005) and Deputy Chairman of Supervisory Board at Epigenomics AG.
- Board of the University Marburg.
- Board of Trustees of the Aventis Foundation.
- Non-Executive Director of Oxford GlycoSciences Plc.
- Board member of HoechstMarionRoussel AG, Bertelsmann Stiftung (2008), and Boehringer Mannheim GmbH (Roche AG).
- Advisory Board at CVC Capital Partners Ltd.
- Supervisory Board member of Future Capital, and Definiens AG.
- Director of MedImmune Limited (1999).
Robert Castaigne (1946-)
- Board of Directors since 2000.
- Begining Career (1972); Secretary of the Executive committee (1985-1990); Vice Chief Financial Officer and Member of the Steering committee (1990-1994); Chief Financial Officer (1994-2008) of Total S.A.
- Chairman of the Board of Directors of Total Chimie and Total Nucléaire.
- Director of Hutchinson S.A.; Petrofina; TEP Algérie; Omnium Insurance and Reinsurance Company Limited; Société Financière d'Auteuil; Eramet S.A. (1999); and Compagnie Générale de Géophysique-Veritas (1992-2004).
- Non-executive director of Vinci (2007), and Compagnie nationale à portefeuille (2008).
- Director of Total Nigeria Ltd.; Total Fina Elf Exploration Norge; Total Fina Elf Holdings UK; Total Fina Elf Exploration UK; Total Gabon; Total Gestion Filiales; Atofina Petrochemicals Inc.; Elf Aquitaine.
Thierry Desmarest (1946-)
- Board of Directors since 2000.
- Management positions (1981), President of Exploration & Production, Chief Executive Officer (1995-2007) and Chairman of Total S.A.
- Director of Bombardier Inc. (2009), Air Liquide Tunisie (1999), Paris EUROPLACE, Air Liquide Canada Inc., Renault SAS, and Renault S.A..
- Chairman and Chief Executive Officer of Paulstra CRC Corporation.
- Supervisory Board of Areva.
- Advisory Council of Banque de France.
- Technical Advisor at the Ministry of Industry and the Ministry of Economic Affairs of the Government of France.
Lindsay Owen-Jones (1946-)
- Board of Directors since 1999.
- Director of Ferrari S.P.A.; BNP Paribas (1989); and Gesparal.
- Director (1994-2001) and Vice Chairman of Supervisory Board (2001-2009) of L'Air Liquide S.A..
- Chairman of Galderma Pharma S.A., Switzerland.
- Chief Executive Officer of L'Oréal Group and its subsidiary L'Oreal S.A. (1988-2006) and Chairman (2006).
- President of L'Oréal USA (1981-1984).
- Chief Executive of L'Oréal Italy (1978-1981).
- MBA from Oxford University in 1968.
- Commander of the Légion d'Honneur and Commander and Knight Commander of the British Empire.
Serge Weinberg (1951-)
- Non-executive Chairman of the Board since May 2010.
- Member of the Trilateral Commission.
- Vice-Chairman of the Supervisory Board of Schneider Electric.
- Director of Fnac, Artémis, and Gucci.
- Board of the French Association of Private Enterprises.
- Founding Member and Treasurer of the Brain and Spinal Cord Institute.
- Chairman of the Board of Corum since 2008.
- Founder of the investment firm Weinberg Capital Partners.
- Member of the "Growth Release Committee" (Attali Committee, 2007-2008).
- Non-Executive Chairman of the Board of Accor Group (2006-2009).
- At Pinault Group: CEO of CFAO; Chairman and CEO of Rexel (1991-1995); Chairman of the Management Board (1995-2005) of PPR, the largest non-food retailer in Europe and the 3rd largest multibrand luxury goods company in the world.
- General Manager with investment bank Pallas Groupe (1987-1990).
- Chief Executive Officer and Chairman of the Havas Tourisme Group (1983-1987).
- Deputy General Manager for Finance at the French Television Channel FR3 (1982-1983).
- Civil servant in the French administration (1976-1981); Chief of Staff of the French Budget Minister (1981-1982).
- Bachelor's degree in Law, Graduate Degree of Institut d'Études Politiques, and Graduate of the Ecole Nationale d'Administration (1976).
Former Members
Gunter Thielen (1944-)
- Board of Directors (2008-2009), resigned for personal reasons.
- Chief Executive Officer of Thiel Logistik AG.
- Chairman and Chief Executive Officer of Bertelsmann AG.
- Non-Executive Director of RTL Group S.A. (2002-2007).
- Supervisory Board of Arcandor AG; Sixt Aktiengesellschaft (2008); Leipziger Messe GmbH; Groupe Bruxelles Lambert; Hannoversche Leben VVaG; Saar LB; and Gruner & Jahr Ag & Druck-und Verlagshaus.
- Chairman of the Board and Director of Arvato AG.
- Executive Board of Berryville Graphics Inc., Cobrhi S.A., Bertelsmann Holding Spain S.A. (Sony Music Entertainment Inc.).
- Head of Management of Maul-Belser (1980).
Gérard Le Fur
- Executive Vice President, Scientific and Medical Affairs (2004), and Chief Executive Officer (2007).
- Senior Executive Vice President (2003) at Sanofi-Synthelabo.
- Associate Director of Research and Development (1986); Director of Research and Development (1995); Managing Director in charge of Scientific Departments (1998) at Sanofi.
- Corresponding Member of the French Academy of Sciences.
- Director of Biology at Laboratoires Rhone-Poulenc.
- Chief of Laboratories and Assistant Director of Research and Development at Laboratoires Pharmuka.
Timothy Rothwell
- US President, Chairman and CEO (2004-2009).
- Board of directors of Antigenics Inc.; PhRMA; the Institute of Medicine's Evidence-Based Medicine Roundtable; and the CEO Roundtable on Cancer.
- US president and chief executive officer at Sanofi-Synthelabo (2003).
- Executive Vice President and President of Global Prescription Business of Pharmacia Corporation (2001-2003).
- Executive Vice President and President Global Pharmaceutical Operations of Pharmacia & Upjohn Inc. (1998-2000).
- Senior management positions at Rhne-Poulenc Rorer (1995-1998) and Bristol-Myers Squibb Co (1989-1991).
- Begining career (1972), operational positions and Chief Executive Officer and President of the U.S. pharmaceutical business of Sandoz Pharmaceuticals.
- Bachelor of arts from Drew University in New Jersey and law degree from Seton Hall University in New Jersey.
Nigel Brooksby
- UK General Manager and Managing Director since September 2004.
- Head of Sanofi-Synthelabo in the UK.
- Joined Sanofi in 1992 after working for Pfizer.
- Chairman of Commercial Affairs Group; Board of Management (1999); President (2006) of the Association of the British Pharmaceutical Industry.